Impact Evaluation of Benazir Nashonuma Program (BNP) on Stunting Among Under-five Children
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-59
SponsorAga Khan University
About this trial
The aim of the study is to evaluate the impact of Benazir Nashonuma Program (BNP) on prevalence of stunting among under-five children in low income setting of Pakistan. The research question that the study aims to answer is:
Is there any change in the prevalence of stunting among under-five children in districts where Benazir Nashonuma Program (BNP) is established compared to districts where BNP is not established?
Districts where BNP is functional, and women and children are receiving the intervention will be compared at baseline and end line with control districts where conventional reproductive care services are given. Prevalence of stunting among under-five children will be compared along with other nutritional and growth status indicators over a period of 4 years.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
An under-five child with a mother registered with Benazir Income Support Program (BISP)
Both available at the time of interview
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Benazir Nashonuma Program (BNP)
Combination productBenazir Nashonuma Program (BNP) Dietary supplement for pregnant women and lactating mothers during the first six months of lactation: Maamta is a 75-gram sachet made from peanut butter with 400 kcal of energy Dietary supplement for children aged 6-23 months: Wawamum is a lipid-based nutrient supplement consisting of skimmed milk powder, micronutrients, vegetable oil, roasted chickpeas and antioxidants. Wawamum covers the recommended daily dose of most micronutrients and 255 kcal of energy. Conditional Cash Transfer (CCT): This includes stipends of PKR 2000 during pregnancy contingent on three antenatal care visits, consuming SNF, attending awareness sessions on health and nutrition, getting two doses of tetanus toxoid and institutional delivery. After delivery PKR 2000/- for boys and 2500/- for girls are paid as incentives conditioned on getting child's birth registered, routine immunization and consumption of SNF by the child from 6-23 months
Treatment groups
13,200 Participants
are divided into 2 treatment groupsGroup A: Districts with established and operational BNP implementationExperimental treatment 1 intervention
Group B: Districts without BNP implementation and functionalityNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Baseline to end-line change in the prevalence of stunting among children 0-59 months of age
Height-for-age ≤-2 SD of the WHO Child growth standards median
Time frame
3 years (on study completion)Secondary outcomes
1
Baseline to end-line change in the prevalence of underweight women of reproductive age (15-49 years)
WRA with a Body Mass Index (BMI) less than 18.5 kg/m2 will be considered underweight
Time frame
3 years (on study completion)2
Baseline to end-line change in the prevalence of wasting among children 0-59 months of age
Weight-for-height ≤-2 SD of the WHO Child growth standards median
Time frame
3 years (on study completion)3
Baseline to end-line change in the prevalence of food insecurity status at household level
Food Insecurity Experience Scale (FIES) by Food and Agriculture Organization (FAO) is experience-based measures of household or individual food security. It consists of eight questions regarding people's access to adequate food in last 12 months due to lack of money or other resources. Food insecurity is reported as mild, moderate and severe.
Time frame
3 years (on study completion)4
Baseline to end-line change in the number of antenatal care (ANC) visits during pregnancy
Number of antenatal care (ANC) visits done during the preceding pregnancy, leading to a live birth within the last two years.
Time frame
3 years (on study completion)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Aga Khan University
Lead sponsor
International Food Policy Research Institute
Collaborator
Bill and Melinda Gates Foundation
Collaborator
Source ClinicalTrials.gov